BELLUS Health Inc. (BLUSF)

[BYUINSDER]

at the conference call with Mutual Fund managers and NRMX scientists last month after the FDA shot down NRMX drug application the NRMX scientists said " They would review the test results from the Phase 3 trials more closely...then give us a statement in two months of the results....or their findings.....

$80 million in cash...with several drugs coming out IF they can get FDA approval....

Johnson and Johnson sub company gave $40 million to NRMX..

so there is some huge risk...

But long term (months) we could see $24

Very hard to predict how high it may go If they can clear the FDA hurdles...

I wouldbe happy with $15

But i think everyone waiting for Nov to hear back from NRMX scientists...on their opinion to the phase 3 results..

I'm thinking they will try and alter the results...to slip by the FDA...